Volume 5 Number 2 June 2009

EuroIntervention and EuroPCR 2009. A truly "Grand Cru"

• Serruys PW

EuroIntervention 2009;5:167

Transcatheter Aortic Valve Implantation. Where are we?

• de Jaegere P,
• Ruiz C,
• Bonhoeffer P,
• Vahanian A,
• Marco J,
• Serruys PW

EuroIntervention 2009;5:169-171

Notes on clubs and the forming of group identity

• Wijns W

EuroIntervention 2009;5:173-175

Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting

• García-García HM,
• Mintz G,
• Lerman A,
• Vince G,
• Margolis P,
• Van Es G-A,
• Morel M,
• Nair A,
• Virmani R,
• Burke A,
• Stone G,
• Serruys PW

EuroIntervention 2009;5:177-189

Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)

• Routledge H,
• Lefèvre T,
• Colombo A,
• Oldroyd K,
• Hamm C,
• Guagliumi G,
• von Scheidt W,
• Guetta V,
• Ruzyllo W,
• Wittebols K,
• Goedhart D,
• Serruys PW

EuroIntervention 2009;5:190:196

Long-term outcome after the V stenting technique in de novo bifurcation lesions using drug-eluting stents

• Girasis C,
• Onuma Y,
• Wong C,
• Kukreja N,
• van Domburg R,
• Serruys PW

EuroIntervention 2009;5:197-205

Ovalum CiTop™ Expander™: a novel guidewire for crossing coronary chronic total occlusions – first-in-man (FIM) experience

• Parikh K,
• Shah A,
• Chag M,
• Segev A

EuroIntervention 2009;5:206-211

Intravascular ultrasound measures of coronary atherosclerosis are associated with the Framingham risk score: an analysis from a global IVUS registry

• Marso S,
• Frutkin A,
• Mehta S,
• House J,
• McCrary J,
• Klauss V,
• Lerman A,
• Leon M,
• Nair A,
• Margolis P,
• Erbel R,
• Nasu K,
• Schiele F,
• Margolis J

EuroIntervention 2009;5:212-218

Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON)

• Rozenman1 Y,
• Witzling V,
• Tamari I,
• Turkisher V,
• Kriviski M,
• Bode C,
• Henry P,
• Teiger E,
• Cebrian A,
• Stoll H,
• Spaulding C

EuroIntervention 2009;5:219-223

Reproducibility of quantitative optical coherence tomography for stent analysis

• Gonzalo N,
• García-García HM,
• Serruys PW,
• Commissaris K,
• Bezerra H,
• Gobbens P,
• Costa M,
• Regar E

EuroIntervention 2009;5:224-232

The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)

• Verheye S,
• Sarno G,
• Muller R,
• Birkemeyer R,
• Vrints C,
• Jung W,
• Agostoni P,
• van Langenhove G,
• Haine S,
• Willems T,
• Haude M,
• Grube E,
• Wijns W

EuroIntervention 2009;5:224-232

Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention

• Lemos P,
• Campos C,
• Falcão J,
• Ribeiro E,
• Perin M,
• Kajita L,
• Filho E,
• da Gama M,
• Horta P,
• Marchiori G,
• Spadaro A,
• Martinez E

EuroIntervention 2009;5:239-243

Rapid pacing rotational angiography with three-dimensional reconstruction: use and benefits in structural heart disease interventions

• Noble S,
• Miro J,
• Yong G,
• Bonan R,
• Tardif J-C,
• Ibrahim R

EuroIntervention 2009;5:244-249

Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels

• Ferrero V,
• Tomai F,
• Versaci F,
• Feola M,
• Proietti I,
• Rognoni A,
• Ghini A,
• Gaspardone A,
• Vacca G,
• De Luca L,
• Vassanelli C,
• Ribichini F

EuroIntervention 2009;5:250-254

Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study Alfredo E.

• Rodriguez A,
• Maree A,
• Tarragona S,
• Fernandez-Pereira C,
• Santaera O,
• Granillo R,
• Rodríguez-Granillo G,
• Russo-Felssen M,
• Kukreja N,
• Antoniucci D,
• Palacios I,
• Serruys PW

EuroIntervention 2009;5:255-264

Use of the Heartrail II catheter as a distal stent delivery device; an extended case series

• Mamas M,
• Eichhofer E,
• Hendry C,
• El-Omar M,
• Clarke B,
• Neyses L,
• Fath-Ordoubadi F,
• Fraser D

EuroIntervention 2009;5:265-271

Impact of dye injection on intracoronary pressure

• Stoel M,
• Kandhai-Ragunath J,
• Van Houwelingen G,
• von Birgelen C

EuroIntervention 2009;5:272-276

Coronary stenting in warfarin treated patients

• Zahger D,
• Ilia R

EuroIntervention 2009;5:277-281